Merit Medical Systems, Inc. (MMSI)

NASDAQ: MMSI · Real-Time Price · USD
85.79
+0.70 (0.82%)
At close: Nov 17, 2025, 4:00 PM EST
85.79
0.00 (0.00%)
After-hours: Nov 17, 2025, 4:00 PM EST
0.82%
Market Cap5.09B
Revenue (ttm)1.48B
Net Income (ttm)118.43M
Shares Out 59.29M
EPS (ttm)1.95
PE Ratio44.52
Forward PE22.24
Dividendn/a
Ex-Dividend Daten/a
Volume1,164,944
Open84.88
Previous Close85.09
Day's Range84.88 - 87.42
52-Week Range78.12 - 111.45
Beta0.61
AnalystsStrong Buy
Price Target105.38 (+22.78%)
Earnings DateOct 30, 2025

About MMSI

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bo... [Read more]

Sector Healthcare
IPO Date Aug 9, 1990
Employees 7,400
Stock Exchange NASDAQ
Ticker Symbol MMSI
Full Company Profile

Financial Performance

In 2024, Merit Medical Systems's revenue was $1.36 billion, an increase of 7.89% compared to the previous year's $1.26 billion. Earnings were $120.36 million, an increase of 27.48%.

Financial Statements

Analyst Summary

According to 8 analysts, the average rating for MMSI stock is "Strong Buy." The 12-month stock price target is $105.38, which is an increase of 22.78% from the latest price.

Price Target
$105.38
(22.78% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Carillon Eagle Small Cap Growth Fund Q3 2025 Portfolio Update

Small-cap stocks extended their momentum into the third quarter. We believe Rambus' evolution from a licensing and patent company into a full-fledged product company is progressing well. Shake Shack s...

4 days ago - Seeking Alpha

Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial

SOUTH JORDAN, Utah, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced 24-month efficacy findings from the non-rand...

14 days ago - GlobeNewsWire

Merit Medical Systems, Inc. (MMSI) Q3 2025 Earnings Call Transcript

Merit Medical Systems, Inc. ( MMSI) Q3 2025 Earnings Call October 30, 2025 5:00 PM EDT Company Participants Martha Aronson - President, CEO & Director Brian Lloyd - Chief Legal Officer & Corporate Se...

17 days ago - Seeking Alpha

PENTAX Medical Announces Sale of C2 CryoBalloon™ Product Line to Merit Medical Systems through Asset Purchase Agreement

Transaction supports PENTAX Medical's strategic focus on core flexible reusable endoscopy MONTVALE, N.J. , Oct. 15, 2025 /PRNewswire/ -- PENTAX Medical, a division of HOYA Group and a global leader in...

4 weeks ago - PRNewsWire

Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025

SOUTH JORDAN, Utah, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will rele...

6 weeks ago - GlobeNewsWire

Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology

SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care

6 weeks ago - GlobeNewsWire

Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis

Expanded indication provides patients with knee osteoarthritis the benefits of Embosphere's consistent, predictable, and effective clinical results. Expanded indication provides patients with knee ost...

2 months ago - GlobeNewsWire

Merit Medical Has To Rebuild Some Confidence In The Growth Story

Merit Medical has faced near-term headwinds from tariffs and a Wrapsody reimbursement error, but core operations remain fundamentally strong. Wrapsody's reimbursement setback is a risk, but resolution...

2 months ago - Seeking Alpha

First Patient Enrolled in Merit Medical's WRAPSODY (WRAP) North America Registry

SOUTH JORDAN, Utah, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today the successful enrollment of the first patie...

3 months ago - GlobeNewsWire

Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology

Thin-wall design with superior insertion and unique sheath-securement solution to support successful radial access procedures and may aid in reducing arterial spasm and occlusion Thin-wall design with...

3 months ago - GlobeNewsWire

Merit Medical Systems, Inc. (MMSI) Q2 2025 Earnings Call Transcript

Merit Medical Systems, Inc. (NASDAQ:MMSI) Q2 2025 Earnings Conference Call July 30, 2025 5:00 PM ET Company Participants Brian G. Lloyd - Chief Legal Officer & Corporate Secretary Fred P.

3 months ago - Seeking Alpha

Merit Medical Names Martha Aronson as New President and Chief Executive Officer

Fred Lampropoulos will continue to serve as Chairman of Merit's Board of Directors Merit announces preliminary unaudited revenue for the quarter ended June 30, 2025 SOUTH JORDAN, Utah, July 07, 2025 (...

4 months ago - GlobeNewsWire

Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025

SOUTH JORDAN, Utah, July 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will rele...

4 months ago - GlobeNewsWire

The Market Is Vulnerable. 6 ‘Defensive' Stocks to Buy Now.

Stocks that aren't sensitive to economic ups and downs are a smart way to protect your portfolio.

Other symbols: CRMEXCMSI
5 months ago - Barrons

Merit Medical Acquires Biolife Delaware, L.L.C.

SOUTH JORDAN, Utah, May 20, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that it has acquired Biolife Delaware, L.L.C....

6 months ago - GlobeNewsWire

Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis

SOUTH JORDAN, Utah, May 06, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that the Wrapsody Cell-Impermeable Endoprosth...

6 months ago - GlobeNewsWire

Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial

In the AVG cohort of the US pivotal trial, the Merit WRAPSODY Cell-Impermeable Endoprosthesis (CIE) achieved 60.2% target lesion primary patency (TLPP) at 12 months. In the AVG cohort of the US pivota...

7 months ago - GlobeNewsWire

Merit Medical Systems, Inc. (MMSI) Q1 2025 Earnings Call Transcript

Merit Medical Systems, Inc. (NASDAQ:MMSI) Q1 2025 Results Conference Call April 24, 2025 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman & Chief Executive Officer Raul Parra - C...

7 months ago - Seeking Alpha

Merit Medical Launches the Ventrax™ Delivery System

Novel all-in-one retrograde aortic access delivery system supports streamlined treatment of ventricular tachycardia Novel all-in-one retrograde aortic access delivery system supports streamlined treat...

7 months ago - GlobeNewsWire

Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025

SOUTH JORDAN, Utah, April 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will rel...

8 months ago - GlobeNewsWire

Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERD

Endoscopic anti-reflux therapy recognized as evidence-based approach to providing relief of GERD symptoms. Endoscopic anti-reflux therapy recognized as evidence-based approach to providing relief of G...

8 months ago - GlobeNewsWire

Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)

SOUTH JORDAN, Utah, March 25, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that the six-month results from the randomi...

8 months ago - GlobeNewsWire

Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership

SOUTH JORDAN, Utah, March 18, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced that Chairman and Chief Executive Officer, Fred L...

8 months ago - GlobeNewsWire

Merit Medical: A Success Story That Keeps Getting Better

Merit Medical continues to outperform, with the share price supported by on-target financial results, incremental M&A, and positive clinical data. The company's Wrapsody stent graft showed almost best...

8 months ago - Seeking Alpha

First Patient Enrolled in Merit Medical's PREEMIE Study

Multicenter, prospective study designed to evaluate safety and efficacy of Bloom™ Micro Occluder System for treatment of patent ductus arteriosus in premature infants Multicenter, prospective study de...

9 months ago - GlobeNewsWire